Loading...
News Category – Vivo News2021-12-04T08:59:23-08:00

Categories

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

November 8th, 2018|
Go to Top